NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
Seeking Alpha5/15/2026Neutral
NXGL
Nexgel IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$4.03M
P/E Ratio
—
EPS
$-0.40
Beta
0.76
52W High
$2.89
52W Low
$0.41
50-Day MA
$0.53
200-Day MA
$1.21
Dividend Yield
—
Profit Margin
-28.50%
Forward P/E
1.38
PEG Ratio
—
About Nexgel Inc
NEXGEL, Inc. manufactures aqueous, electron beam crosslinked, high water content hydrogels and polymeric gels. The company is headquartered in Langhorne, Pennsylvania.
Fundamentals
| Revenue (TTM) | $11.27M |
| Gross Profit (TTM) | $4.38M |
| EBITDA | $-3.10M |
| Operating Margin | -36.10% |
| Return on Equity | -61.40% |
| Return on Assets | -20.00% |
| Revenue/Share (TTM) | $1.41 |
| Book Value | $0.47 |
| Price-to-Book | 1.01 |
| Price-to-Sales (TTM) | 0.36 |
| EV/Revenue | 0.722 |
| EV/EBITDA | -0.85 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -5.60% |
| Shares Outstanding | $9.23M |
| Float | $7.08M |
| % Insiders | 14.59% |
| % Institutions | 13.57% |
Historical Volatility
HV 10-Day
75.46%
HV 20-Day
83.47%
HV 30-Day
91.37%
HV 60-Day
91.41%
HV Rank
54.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.00 target)
1
Strong BuyLatest News
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day LANGHORNE, Pa.
GlobeNewsWire5/12/2026Neutral
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
Seeking Alpha4/21/2026Neutral
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/17/2026Neutral
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
LANGHORNE, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 23, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/15/2026Neutral
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
LANGHORNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the rescheduling of its shareholder update conference call to April 15, 2026, at 4:30 P.M. ET.
GlobeNewsWire4/8/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NXGL and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026